DETAILS

Objectives

This initiative will present the science of the endocannabinoid system, risks, efficacy, and how to approach cannabinoids as an option in patient care. After participating in this event, attendees will:

  • Understand recent developments in medical and nonmedical cannabis regulations
  • Be aware of Canadian cannabinoid research initiatives
  • Appreciate actual and potential health risks and benefits of cannabinoids
  • Reflect on professional attitudes towards cannabis in clinical practice
  • Recognize areas of need for cannabinoid research, education and collaboration

Supported in part by a Canadian Institutes of Health Research (CIHR) Planning and Dissemination Grant– Institute Community Support funding award



Certificates of attendance

Letters of attendance will be available online following the course. Participants will be e-mailed information within two weeks after completion of the course specifying how to obtain their letter of accreditation/attendance online.

For questions about certificates, please contact:  facmed.registration@utoronto.ca  

Tel: 416.978.2719 / Toll free: 1.888.512.8173

Reflective Exercise for Registrants (Pre-event & Post-event)

This voluntary survey is for registrants of the Cannabinoids in Clinical Practice event. The goals of this survey are to: gather information about the registrants to inform speakers of the audience, provide an opportunity for registrants to reflect on their clinical experiences with cannabinoids and identify educational learning needs and practice gaps and establish a baseline level of clinical knowledge on cannabinoids, and identify additional educational needs on cannabinoids in clinical practice.

Registrants are encouraged to complete this survey twice: once prior to the event and once afterwards. Reflecting on clinical experiences and perceived knowledge levels both before and after the event will provide participants with the ability to consider potential changes to practice as a result of their participation.

Survey coming soon

 

Steering Committee

  • Bernard Le Foll, MD PhD CCFP (Co-Chair)
  • Mark A. Ware, MD MSc MBBS MRCP (Co-Chair)
  • Lynda G. Balneaves, RN (BC), PhD
  • Paul Daeninck, MD MSc FRCPC
  • Matthew Hill, PhD
  • Colleen O’Connell, MD FRCPC
  • Danial Schecter, MD, CCFP
  • Beth Sproule, RPh, BScPhm, PharmD

Contact

For more information please contact:

Bryce Mansell, Administrative Assistant
Canadian Consortium for the Investigation of Cannabinoids
Email: info@ccic.net
Tel: 514-934-1934 ext. 44362
Fax: 514-934-8491